Specific Therapy for Transthyretin Cardiac Amyloidosis: A Systematic Literature Review and Evidence-Based Recommendations.

The results of the other parameters did not reach statistical significance (Table 2 ). 7 , 8 , 9 No significant safety issues related to patisiran were found in these studies (Table 2 and Table 3 ). 7 , 8 , 9 , 14 Tetramer Stabilization Diflunisal Diflunisal was assessed in 4 non‐RCTs, with a small number of patients included in each study

also in 111,027 other papers